Dr. Silberstein is a professor of neurology and director of the Jefferson Headache Center at Thomas Jefferson University in Philadelphia, PA; one of few academic headache centers in the country. He is extensively involved with migraine research and clinical trials, and has authored over 300 peer-reviewed publications.
Core Competencies include: headache guidelines, clinical trials.
Stephen D. Silberstein, M.D., is Professor of Neurology and Director of the Jefferson Headache Center at Thomas Jefferson University. He is a Fellow of the American College of Physicians, the American Academy of Neurology, and the American Headache Society. He has served the American Headache Society as President, Treasurer, and Board of Directors member. In 2016, he was awarded a Lifetime Achievement Award by the American Headache Society. He has served on the Publications, Scientific, and Education Committees of the American Headache Society and was Co-Chairman of the Annual Scientific Meeting. Dr. Silberstein is an active member of the American Academy of Neurology and was Co-Director of the national and international Headache Guideline Project. He was the chairman of the International Headache Society meeting in Philadelphia in 2009. He is chairman of the headache research group of the World Federation of Neurology and President of the Philadelphia Headache Society.
Dr. Silberstein is the senior editor of the 8th edition of Wolff’s Headache and Other Head Pain, Associate Editor of Cephalalgia and CNS Drugs, and a present or prior member of the Editorial Board of Headache, Cephalalgia, Acta Neurologica Scandanavia, Journal of Neurology, Neurosurgery and Psychology, and Topics in Pain Management. He is also an ad hoc reviewer for many publications, and has more than 300 peer-reviewed publications to his credit.
Dr. Silberstein received his medical degree from the University of Pennsylvania. He did a medical internship at the Hospital of the University of Pennsylvania. After completing a fellowship in neurology at the National Hospital for Nervous Diseases in London, Dr. Silberstein completed a medicine/neurology residency at the Hospital of the University of Pennsylvania. He served as a pharmacology research associate in the Toxicology Laboratory of Clinical Science at the National Institutes of Mental Health and completed a neurology residency at the Hospital of the University of Pennsylvania.